Discovery of pyrazolo[1,5-a]pyrimidin-7-amine derivatives as mTOR kinase domain inhibitors: Hit to lead optimization

被引：0

作者：

Deng, Yongqi ^{[1
]}

Sun, Binyuan ^{[1
]}

Shipps, Gerald ^{[1
]}

Matthew, Richards ^{[1
]}

Meng, Zhaoyang ^{[1
]}

Windsor, Williama ^{[1
]}

Zeng, Hongbo ^{[1
]}

Long, Brian ^{[1
]}

Xiao, Li ^{[1
]}

机构：

[1] Merck Res Labs, Drug Discovery, Boston, MA 02115 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 248卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

165-MEDI

引用

页数：1

共 50 条

[1] Hit to lead optimization of pyrazolo[1,5-a]pyrimidines as B-Raf kinase inhibitors
Gopalsamy, Ariamala
Ciszewski, Greg
Shi, Mengxiao
Berger, Dan
Hu, Yongbo
Lee, Frederick
Feldberg, Larry
Frommer, Eileen
Kim, Steven
Collins, Karen
Wojciechowicz, Donald
Mallon, Robert
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (24) : 6890 - 6892
[2] Acidity constant and solvatochromic behavior of some pyrazolo[1,5-a]pyrimidin-2-amine derivatives
El-Gahami, Mohamed A.
Mekky, Ahmed E. M.
Saleh, Tamer S.
Al-Bogami, Abdullah S.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2014, 129 : 209 - 218
[3] Discovery of 4H-pyrazolo[1,5-a]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase
Deng, Yongqi
Shipps, Gerald W., Jr.
Wang, Tong
Popovici-Muller, Janeta
Rosner, Kristin E.
Siddiqui, M. Arshad
Duca, Jose
Cooper, Alan B.
Cable, Michael
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (18) : 5363 - 5367
[4] Discovery of Pyridazinone and Pyrazolo[1,5-a]pyridine Inhibitors of C-Terminal Src Kinase
O'Malley, Daniel P.
Ahuja, Vijay
Fink, Brian
Cao, Carolyn
Wang, Cindy
Swanson, Jesse
Wee, Susan
Gavai, Ashvinikumar V.
Tokarski, John
Critton, David
Paiva, Anthony A.
Johnson, Benjamin M.
Szapiel, Nicolas
Xie, Dianlin
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (10): : 1486 - 1491
[5] Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors
Stevens, KL
Jung, DK
Alberti, MJ
Badiang, JG
Peckham, GE
Veal, JM
Cheung, M
Harris, PA
Chamberlain, SD
Peel, MR
ORGANIC LETTERS, 2005, 7 (21) : 4753 - 4756
[6] Discovery of Pyrazolo[1,5-a]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors
Wang, Chun
Zou, Fengming
Qi, Ziping
Liu, Qingwang
Shen, Lijuan
Yuan, Xinyu
Deng, Maoqing
Wang, Aoli
Wang, Beilei
Wang, Li
Liang, Xiaofei
Liu, Qingsong
Liu, Jing
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (17) : 15199 - 15219
[7] Optimization of pyrazolo[1,5-a]pyrimidines lead to the identification of a highly selective casein kinase 2 inhibitor
Kraemer, Andreas
Kurz, Christian Georg
Berger, Benedict-Tilman
Celik, Ibrahim Ethem
Tjaden, Amelie
Greco, Francesco Aleksy
Knapp, Stefan
Hanke, Thomas
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
[8] Discovery of pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitors
Kendall, Jackie D.
O'Connor, Patrick D.
Marshall, Andrew J.
Frederick, Raphael
Marshall, Elaine S.
Lill, Claire L.
Lee, Woo-Jeong
Kolekar, Sharada
Chao, Mindy
Malik, Alisha
Yu, Shuqiao
Chaussade, Claire
Buchanan, Christina
Rewcastle, Gordon W.
Baguley, Bruce C.
Flanagan, Jack U.
Jamieson, Stephen M. F.
Denny, William A.
Shepherd, Peter R.
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (01) : 69 - 85
[9] Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors
Balestri, Francesco
Quattrini, Luca
Coviello, Vito
Sartini, Stefania
Da Settimo, Federico
Cappiello, Mario
Moschini, Roberta
Del Corso, Antonella
Mura, Umberto
La Motta, Concettina
CELL CHEMICAL BIOLOGY, 2018, 25 (11): : 1414 - +
[10] Discovery of novel Rho kinase inhibitors: Hit generation and lead optimization
Alexander, Brian G.
Pireddu, Roberta
Sun, Nan N.
Yu, Huidong
Forinash, Kara D.
Martin, Matthew P.
Schonbrunn, Ernst
Guida, Wayne C.
Sebti, Said M.
Lawrence, Nicholas J.
CANCER RESEARCH, 2011, 71

← 1 2 3 4 5 →